鲁股观察 | 6000万-1.2亿元，英派斯拟获控股股东增持

Core Viewpoint - Qingdao Inpais Health Technology Co., Ltd. (stock code: 002899) announced a share buyback plan by its controlling shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., with a commitment to increase its stake in the company within six months, reflecting confidence in the company's future development and long-term investment value [1][3]. Group 1: Share Buyback Plan - Hainan Jiangheng plans to increase its shareholding in Inpais with an investment between RMB 60 million and RMB 120 million using bank loans and self-funding [1][3]. - The buyback will not have a set price range, allowing Hainan Jiangheng to act based on market trends and the perceived value of the shares [3]. - China Everbright Bank has committed to providing a special loan of up to RMB 100 million to support the share buyback [3]. Group 2: Current Shareholding and Market Position - As of the announcement date, Hainan Jiangheng holds 40.66 million shares, accounting for 27.51% of the total share capital, making it the largest shareholder of Inpais [3]. - The buyback is intended to boost investor confidence and ensure the company's sustainable and healthy development [3]. Group 3: Financial Performance - In the first three quarters, Inpais reported a net profit attributable to shareholders of RMB 50.75 million, a decrease of 41.88% year-on-year, indicating ongoing performance challenges [5][6]. - The company's revenue for the first half of the year was RMB 574 million, showing a slight increase of 0.47% compared to the previous year, but the net profit decreased by 38.09% [6]. - The company faces significant pressure on its financial performance, necessitating internal improvements to ensure the success of the buyback plan [6].